GlassScriptPhysician profile
James C Charles
NPI 1962405316
$7,741.37
in general payments reported to CMS, 2019-2025
19 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $979 · 2021: $940 · 2022: $1,387 · 2023: $1,317 · 2024: $1,137 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,509.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $3,219.69 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $2,666.66 | 2019-2025 | Biktarvy |
| Abbvie INC. | $670.37 | 2019-2024 | |
| Janssen Biotech, INC. | $239.57 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $191.03 | 2020-2025 | Pifeltro, Delstrigo |
| Napo Pharmaceuticals INC | $160.87 | 2019-2022 | |
| Janssen Products, LP | $159.00 | 2019-2020 | |
| Novo Nordisk INC | $146.34 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Alkermes, INC. | $56.23 | 2019-2023 | Vivitrol |
| Theratechnologies INC. | $49.27 | 2021-2022 | |
| Shield Therapeutics INC | $43.58 | 2025 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Indivior INC. | $18.54 | 2025 | Sublocade |
| Redhill Biopharma INC. | $17.64 | 2023 | Movantik, Talicia, Aemcolo |
| Hologic Sales and Service, LLC | $17.24 | 2024 | Thinprep 2000 Processor, Aptima |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.00 | 2021 | |
| Pfizer INC. | $14.53 | 2025 | |
| Emd Serono, INC. | $14.42 | 2022 | |
| Organon LLC | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.